Moderna: 4Q Earnings Snapshot

February 26, 2020 GMT

CAMBRIDGE, Mass. (AP) _ Moderna Inc. (MRNA) on Wednesday reported a loss of $124.2 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of 37 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.

The biotechnology company posted revenue of $14.1 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $16.9 million.

For the year, the company reported that its loss widened to $514 million, or $1.55 per share. Revenue was reported as $60.2 million.

Moderna shares have climbed 21% since the beginning of the year. The stock has climbed roughly 10% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA